Abstract Keywords: biomarkers; cancer; exosome; exosome heterogeneity; therapeutics EN
biomarkers cancer exosome exosome heterogeneity therapeutics 1 3 3 07/03/23 20230601 …

Extracellular vesicles (EVs) are an innovative orientation of next‐generation cancer
medicine. In EVs, the exosome is the most exciting domain associated with cancer research …

The incidence of cancer is experiencing a steep rise in recent times. A survey report
produced by GLOBOCAN 2018 estimates about 18.1 million new cases of cancer across 20 …

Exosomes belong to a subpopulation of extracellular vesicles secreted by the dynamic
multistep endocytosis process and carry diverse functional molecular cargoes, including …

Cancer diagnosis and therapy is steadily improving. Still, diagnosis is frequently late and
diagnosis and follow-up procedures mostly are time-consuming and expensive. Searching …

Exosomes are subpopulations of extracellular vesicles (EVs) secreted by cells in normal or
pathological conditions. From an oncological point of view, such vesicles are involved in …

Tumor microenvironment (TME) plays an integral part in the biology of cancer, participating
in tumor initiation, progression, and response to therapy. Exosome is an important part of …

Cancer is a complex disease that is associated with genetic aberrations and subsequent
cellular and noncellular host responses. Tumors harbor diverse cell types that engage in a …

Background Recent advances in cancer biology have highlighted the relevance of
exosomes and nanovesicles as carriers of genetic and biological messages between cancer …

Exosomes, membrane vesicles of 40–100 nm in diameter, are derived from endosomes in
various cells. The bioactive molecules specifically packed into exosomes can be horizontally …